Skip to content

Daycare (out patient) phototherapy - Is it possible for treating neonatal jaundice?

Intermittent vs Continuous phototherapy for the treatment of Neonatal Hyperbilirubinemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/05/004584
Enrollment
100
Registered
2014-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Neonatal Hyperbilirubinemia

Interventions

Intervention1: Intermittent phototherapy: Phototherapy will be given intermittently with "12 hour on" and "12 hour off" cycles. The irradiance was maintained above 30 µW/cm2/nm Control Intervention1:

Sponsors

Fernandez Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All healthy late preterm ( > 34 weeks) and term neonates with neonatal hyperbilirubinemia under phototherapy (as per American academy of Pediatrics 2004 guidelines) for a minimum of 8 hours were included in the study

Exclusion criteria

Exclusion criteria: All the infants with major congenital malformations, those with APGAR scores 18 mg/dL at the time of admission or the rise of bilirubin >0.5mg/dl/hour in initial 8 hours of starting phototherapy, those infants with hemolytic cause of jaundice (DCT positive), those infants with the total serum bilirubin falling in the exchange range at the time of admission, those requiring NICU admission for any reason other than jaundice and those with direct bilirubin > 15% of total bilirubin or direct bilirubin > 1.5mg/dL were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Rate of fall of bilirubinTimepoint: At the stoppage of phototherapy

Secondary

MeasureTime frame
Duration of hospitalizationTimepoint: At the time of discharge;Duration of phototherapyTimepoint: At the stoppage of phototherapy;Failure of phototherapyTimepoint: At the time of discharge;Incidence of rebound PhototherapyTimepoint: At the time of discharge

Countries

India

Contacts

Public ContactDr Srinivas Murki

Fernandez Hospital

dr_monica06@yahoo.com9392470351

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026